Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article appearing in Nashville Medical News and shared by Tennessee Oncology and OneOncology, titled “The Oncology Care Model Value Proposition,” highlighted 2 meetings, Patient-Centered Oncology Care® in Philadelphia, Pennsylvania, and the Institute for Value-Based Medicine® (IVBM) in Nashville, Tennessee, conducted by The American Journal of Managed Care® (AJMC®). The article spotlighted the presentation of featured IVBM speaker Stephen Schleicher, MD, MBA, physician and Tennessee Oncology’s chair of the Quality and Value Committee at OneOncology.
Endpoints News referenced an article from AJMC®’s sister site, The Center for Biosimilars®, titled “AbbVie and Boehringer Ingelheim Settle Over Biosimilar Adalimumab.” The article detailed the announcement of AbbVie's patent litigation settlement with Boehringer Ingelheim over the biosimilar Cyltezo, which references AbbVie’s originator adalimumab, Humira.
Another article from The Center for Biosimilars® was also featured in the November 18, 2019 daily regulatory news and intelligence briefing from Regulatory Focus. The article, “Biosimilars Make Progress in the Canadian Market, but Stakeholders See More Work Ahead,” was included in the In Focus: International section. The article emphasized strides made by Canada in its biosimilar experience.
An article in Williston Herald, “A New Way to Fight Breast Cancer,” highlighted an AJMC® article, “FDA Approves First Breast Cancer Drug to Target PIK3CA Mutation Plus Companion Diagnostic Test.” The article covered the announcement by the FDA of the approval for the novel oral drug alpelisib, sold as Piqray.
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More